Bifidobacterium and Ramelteon drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bifidobacterium (bifidobacteria) and Ramelteon (ramelteon). Common drug interactions include anaemia among females and acute respiratory failure among males.

The phase IV clinical study analyzes what interactions people have when they take Bifidobacterium and Ramelteon. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Bifidobacterium?

Bifidobacterium has active ingredients of bifidobacteria. eHealthMe is studying from 5,013 Bifidobacterium users. Check the latest studies of Bifidobacterium.

What is Ramelteon?

Ramelteon has active ingredients of ramelteon. It is often used in insomnia. eHealthMe is studying from 1,387 Ramelteon users. Check the latest studies of Ramelteon.

On Jul, 13, 2026

14 people who take Bifidobacterium and Ramelteon together, and have interactions are studied.

Bifidobacterium and Ramelteon drug interactions.

What are the common drug interactions of Bifidobacterium and Ramelteon, by gender? *:

female:

Anaemia (lack of blood)
Chronic kidney disease
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Femur fracture
Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
Renal disorder (kidney disease)

male:

Acute respiratory failure
Arrhythmia (irregular heartbeat)
Hypoglycaemia (deficiency of glucose in the bloodstream)
Hypokalaemia (low potassium)
Ilium fracture
Pleural effusion (water on the lungs)
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Spinal compression fracture (fracture due to spinal compression on bone)

What are the common drug interactions of Bifidobacterium and Ramelteon, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Drug clearance decreased
Drug clearance increased
Drug level decreased
Heart transplant rejection

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Decreased appetite
Acute respiratory failure
Hypoglycaemia (deficiency of glucose in the bloodstream)
Hypokalaemia (low potassium)
Ilium fracture
Pleural effusion (water on the lungs)
Pneumonia
Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Spinal compression fracture (fracture due to spinal compression on bone)

What are the existing conditions these people have? *

Infection: 5 people, 35.71%
Gastritis - Chronic (long lasting inflammation of stomach): 4 people, 28.57%
Multiple Myeloma (cancer of the plasma cells): 4 people, 28.57%
Hypokalemia (low potassium): 4 people, 28.57%
Local Anaesthesia: 3 people, 21.43%
Ilium Fracture: 3 people, 21.43%
Hypotension (abnormally low blood pressure): 3 people, 21.43%
Hypoglycemia (low blood sugar): 3 people, 21.43%
Haematochezia (passage of stools containing blood): 3 people, 21.43%
Type 2 Diabetes: 3 people, 21.43%

* Approximation only. Some reports may have incomplete information.

Do you take Bifidobacterium and Ramelteon?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously